wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38566022-2B94F0F4-236E-40C9-9B56-FBE2725A85B3
Q38566022-2B94F0F4-236E-40C9-9B56-FBE2725A85B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38566022-2B94F0F4-236E-40C9-9B56-FBE2725A85B3
Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy.
P2860
Q38566022-2B94F0F4-236E-40C9-9B56-FBE2725A85B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38566022-2B94F0F4-236E-40C9-9B56-FBE2725A85B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fbb944b9a32f59677f573bed709a119c9a6c1e43
P2860
Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C